Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Lung cancer, Non small cell lung cancer (NSCLC), Secondary cancers
Closed
Phase 2
This trial is comparing two combinations of treatment for non small cell lung cancer. The first treatment is chemotherapy, tiragolumab and atezolizumab. And the other is chemotherapy, pembrolizumab and a dummy drug.
It is for people:
whose cancer has grown into surrounding tissues or elsewhere in the body
who haven’t had chemotherapy or an
Recruitment start: 15 January 2021
Recruitment end: 28 February 2022
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Colin Lindsay
Roche
Last reviewed: 01 Mar 2022
CRUK internal database number: 17229
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
